Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Eurofins DiscoverX, a brand of Eurofins Discovery, provides a market-leading portfolio of products and services for drug discovery and development. Specializing in innovative cell-based assays, biochemical assays, target engagement, and in vitro pharmacology, Eurofins DiscoverX supports researchers in academic institutions, biotechnology, and pharmaceutical companies worldwide. Their offerings are designed to accelerate the identification and validation of new drug candidates across various therapeutic areas, including GPCRs, kinases, and immuno-oncology.
This site serves as a key hub for research, development, manufacturing, and commercialization of Eurofins DiscoverX's bioassay technologies and product lines, supporting the global drug discovery market.
The Fremont facility likely houses state-of-the-art laboratories for cell line engineering, assay development, reagent manufacturing, and potentially high-throughput screening services.
The work culture is expected to be science-driven, innovative, and collaborative, focusing on quality and customer support, in line with the broader Eurofins ethos of delivering high-quality scientific services.
The Fremont location benefits from its proximity to the San Francisco Bay Area's rich biotechnology and pharmaceutical ecosystem, facilitating access to talent, collaborations, and market insights. It continues the legacy of DiscoverX's innovation in assay development.
As a brand within Eurofins Discovery, Eurofins DiscoverX leverages a vast global network of laboratories and commercial operations. Eurofins Discovery supports clients across North America, Europe, and Asia-Pacific with a harmonized service offering. This global footprint ensures localized customer support, efficient logistics for products and samples, and access to a comprehensive portfolio of drug discovery services, facilitating international research collaborations and supporting global drug development programs.
42501 Albrae Street
Fremont
California
USA
Address: 22500 Gateway Center Drive, St. Charles, MO 63304, USA
Serves as a key U.S. hub for contract research organization (CRO) services, supporting pharmaceutical and biotech clients across North America and globally with integrated drug discovery solutions.
Address: Eurofins Discovery UK Limited, Tom McDonald Avenue, Dundee, DD2 1NH, Scotland, UK
Acts as a strategic European center for discovery pharmacology and chemistry services, supporting a diverse client base in the UK, continental Europe, and beyond.
Address: Eurofins CEREP SA, Le Bois l'Evêque, 86600 Celle L'Evescault, France
Key European facility providing critical preclinical data and insights for drug development programs to a global pharmaceutical and biotechnology clientele.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Eurofins DiscoverX' leadership includes:
Eurofins DiscoverX has been backed by several prominent investors over the years, including:
No major publicly announced executive hires or exits directly leading Eurofins DiscoverX or within the core Eurofins Discovery leadership team (as listed on their website) have been prominently featured in readily available public news in the last 12 months. The broader Eurofins Scientific group may have experienced changes at various senior levels.
Discover the tools Eurofins DiscoverX uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Personnel at Eurofins DiscoverX, as part of Eurofins, typically use standardized Eurofins email addresses. The most common formats are combinations of first name and last name, or first initial and last name, followed by the @eurofins.com domain.
[firstinitial][lastname]@eurofins.com or [firstname].[lastname]@eurofins.com
Format
jdoe@eurofins.com or jane.doe@eurofins.com
Example
80%
Success rate
Business Wire • February 27, 2024
Eurofins Discovery has launched new preclinical ocular toxicology services to support drug development for ophthalmic indications, expanding its safety and efficacy assessment capabilities for novel therapeutics targeting eye diseases....more
Business Wire • October 17, 2023
Eurofins Discovery announced a significant expansion of its High-Throughput Screening (HTS) capabilities, including enhanced automation and an increased diversity of compound libraries, to better support biopharmaceutical clients in accelerating their early-stage drug discovery programs....more
PR Newswire • June 13, 2023
Eurofins Discovery introduced a suite of new assays specifically designed to support the development of Antibody-Drug Conjugates (ADCs), addressing critical needs in characterizing ADC efficacy and safety....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Eurofins DiscoverX, are just a search away.